Use Case C:

Multi-Centre, Central Contouring Personalized Dosimetry

Lu-DOTATATE Treatment in Patients with 68Ga-DOTATATE Somatostatin Receptor Positive Neuroendocrine Tumors
(ClinicalTrials.gov Identifier: NCT02743741)